SSP Group stock rating cut to Underperform by BNP Paribas Exane

BNP Paribas Exane downgraded SSP Group Plc. to Underperform, significantly cutting its price target from GBP2.60 to GBP1.60, citing concerns over the company's growth merely matching traffic benchmarks, high capital expenditure offsetting stronger margins, and new risks from retail/food & beverage sector convergence. This contrasts sharply with Citi analysts, who recently raised their price target for SSP Group to GBP3.20 while maintaining a Buy rating, projecting robust organic growth and emphasizing the company's adaptive strategies amid industry fluctuations, creating a notable divergence in analyst outlooks for the travel concessions operator.

Analysis

SSP Group faces a stark divergence in analyst sentiment, creating significant uncertainty around its valuation and outlook. BNP Paribas Exane has issued a notable downgrade to Underperform, slashing its price target from GBP2.60 to GBP1.60. Their bearish thesis is anchored on three key concerns: growth that merely tracks local traffic benchmarks without outperformance, high capital expenditure requirements for its expansion plans that are likely to cap cash flows, and a new medium-term structural risk from the convergence of retail and food & beverage sectors, where SSP operates as a pure play. This contrasts sharply with Citi's recent analysis, which maintains a Buy rating and increased its price target to GBP3.20. Citi projects robust organic growth of 9% for fiscal 2025, followed by 6% in both 2026 and 2027, citing the company's adaptive strategies and a shift toward enhancing returns over new contract acquisitions. While the company has demonstrated 11.5% revenue growth over the last twelve months, its high stock volatility, indicated by a beta of 1.76, reflects this conflicting narrative.

Key Decisions for Investors

• Investors must weigh the conflicting narratives from BNP Paribas and Citi, as the investment case hinges on whether one believes the high capex and structural risks will outweigh the potential for strong organic growth.
• Monitor upcoming earnings reports for two key metrics: capital expenditure relative to free cash flow generation, and like-for-like sales growth compared to passenger traffic data to validate either the bearish or bullish thesis.
• Given the stock's high beta of 1.76 and the sharp analyst disagreement, positions should be managed with an awareness of potential for significant price volatility, making it more suitable for investors with a higher risk tolerance.